Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/6/2019
SIETES contiene 92761 citas

 
 
<< anterior 21 a 40 de 2654 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
DeJong C, Aguilar T, Tseng C-W, Lin GA, Boscardin J. Pharmaceutical industry-sponsored meals and physician prescribing patterns for Medicare beneficiaries. JAMA Intern Med 2016;176:1114. [Ref.ID 100701]
22. Cita con resumen
Anónimo. UN panel questions free market approach to R&D for medicines. DIA Daily 2016:1. [Ref.ID 100664]
23. Cita con resumen
Crow D. Poorer countries need rapid access to generic drugs, UN says. Financial Times 2016:1. [Ref.ID 100663]
25. Cita con resumen
Moore N. Lessons from the fatal French study BIA-10-2474. BMJ 2016;353:i2727. [Ref.ID 100424]
26.Enlace a cita original Cita con resumen
Campsall P, Colizza K, Straus S, Stelfox HT. Financial relationships between organizations that produce clinical practice guidelines and the biomedical industry: a Cross-sectional study. PLOS Medicine 2016:31 de mayo. [Ref.ID 100344]
27. Cita con resumen
Casassus B. New report on drug trial disaster in France. Lancet 2016;387:2187. [Ref.ID 100334]
28. Cita con resumen
Yeh JS, Franklin JM, Avorn J, Landon J, Kesselheim S. Association of industry payments to physicians with the prescribing of brand-name statins in Massachusetts. JAMA Intern Med 2016;176:junio. [Ref.ID 100237]
29.Tiene citas relacionadas Cita con resumen
Jaspers L, Feys F, Bramer WM, Franco OH, Leusink P, Laan ETM. Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis. JAMA Intern Med 2016;176:453-62. [Ref.ID 100198]
30.Tiene citas relacionadas Cita con resumen
Woloshin S, Schwartz LM. US Food and Drug Administration approval of flibanserin: even the score does not add up. JAMA Intern Med 2016;176:439-42. [Ref.ID 100197]
31. Cita con resumen
Gubar S. Living with cancer: a broken covenant with patients. N Y Times (Print) 2016:1. [Ref.ID 99979]
32. Cita con resumen
Taichman DB, Backus J, Baethge C, De Leeuw PW, Drazen JM, Fletcher J, Frizelle FA, Groves T, Haileamlak A, James A, Laine C, Peiperl L, Sahni P, Wu S. Sharing clinical trial data — A proposal from the International Committee of Medical Journal Editors. N Engl J Med 2016;374:28 de enero. [Ref.ID 99977]
33.Enlace a cita original Cita con resumen
Jefferson T. Qué hacer ante la desconfianza en los ensayos clínicos publicados. Boletín de Información Farmacoterapéutica de Navarra 2015;23:1-12. [Ref.ID 99656]
34. Cita con resumen
Watson R. Council of Europe tackles drug industry’s “less noble” side. BMJ 2015;351:h5474. [Ref.ID 99593]
35. Cita con resumen
Hawkes N. Modafinil does enhance cognition, review finds. BMJ 2015;351:h4573. [Ref.ID 99412]
37. Cita con resumen
McCarthy M. Industry paid $6.5bn to US physicians and hospitals in 2014. BMJ 2015;351:h3697. [Ref.ID 99244]
38. Cita con resumen
Steinbrook R, Kassirer JP, Angell M. Justifying conflicts of interest in medical journals: a very bad idea. BMJ 2015;350:h2942. [Ref.ID 99149]
39. Cita con resumen
Karimi-Shah BA, Chowdhury BA. Forced vital capacity in idioipathic pulmonary fibrosis - FDA review of pirfenidone and nintedanib. N Engl J Med 2015;372:1189-91. [Ref.ID 98988]
40.Enlace a cita originalTiene citas relacionadas
Smith EMD, Foster HE, Beresford MW. The development and assessment of biological treatments for children. Br J Clin Pharmacol 2015;79:379-94. [Ref.ID 98956]
Seleccionar todas
 
<< anterior 21 a 40 de 2654 siguiente >>